Combination therapy in primary HIV infection

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 87-89

  Perrin, L ^a   Hirschel, B ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Combination therapy; HIV; Protease inhibitors; RT inhibitors

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; ZIDOVUDINE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIMARY INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0029866556     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00925-6     Document Type: Conference Paper

References (6)

1. Fauci, A.S. (1993) Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262, 1011-1018.
2. Kinloch-de Loës, S., Hirschel, B.J., Hoen, B. et al. (1995) A controlled trial of zidovudine in primary human immunodeficiency virus infection. N. Engl. J. Med. (in press).
3. 6/1, AIDS, and death from AIDS? BMJ 309, 1535-1537.
4. Niu, M.T., Jermano, J.A., Reichelderfer, P. and Schnittman, S.M. (1993) Summary of the National Institutes of Health workshop on primary human immunodeficiency virus type-1 infection. AIDS Res. Hum. Retroviruses 9, 913-923.
5. Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O.J. and Demarest, J.F. (1995) Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332, 209-216.
6. Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A. and Deutsch, P. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 17-22.